Patients at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center, the only NCI-designated cancer center in North Texas, have access to treatment options that would otherwise be unavailable to them in the region.
As one of only 30 U.S. cancer research centers named a National Clinical Trials Network Lead Academic Participating Site, UT Southwestern participates in numerous clinical trials in a variety of diseases, and in many cases UTSW physicians and researchers serve as the principal investigators.
Below is a small sampling of cancer clinical trials at UT Southwestern that are currently recruiting appropriate patients.
Clinical Trial: A phase III study evaluating TheraSphere® in patients with metastatic colorectal carcinoma of the liver who have failed first-line chemotherapy
Summary: This is a randomized trial to evaluate the safety and effectiveness of TheraSphere in patients with metastatic colorectal cancer of the liver who have disease progression after first-line chemotherapy.
Patient Eligibility: A patient may be eligible for this trial if he/she:
- Has unresected, metastatic disease to the liver that has progressed after the first treatment
- Is eligible for second-line chemotherapy
- Has a performance status of 0-1
PI: Patrick Sutphin, M.D., Ph.D.
Assistant Professor of Radiology
Clinical Research Manager:Julia Spesivtseva
214-648-7753
Email